Superior Planning LLC’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.2K Buy
+91
New +$10.4K ﹤0.01% 921

Other funds holding KYMR

Superior Planning LLC's KYMR Position: Q3 2026 in Review

Superior Planning LLC opened a new position in Kymera Therapeutics (KYMR) in Q3 2026: 91 shares worth $10.2K. The stake represents ﹤0.01% of the portfolio and ranks #921 among its holdings.

243 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.

  • Superior Planning LLC held 91 shares of Kymera Therapeutics worth $10.2K as of Q3 2026.
  • Kymera Therapeutics was a new Superior Planning LLC position in Q3 2026.
  • Kymera Therapeutics made up ﹤0.01% of Superior Planning LLC's portfolio in Q3 2026, its #921 holding.
  • 243 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.

Based on Superior Planning LLC's 13F filing for Q3 2026, filed 12 Nov 2026.